作者
Xihui Liu,Suryavathi Viswanadhapalli,Shourya Kumar,Taekyung Lee,Andrew S. Moore,Shihong Ma,Liping Chen,Michael Hsieh,Mengxing Li,Gangadhara R. Sareddy,Karla Parra,Eliot B. Blatt,Tanner C. Reese,Yuting Zhao,Annabel Chang,Hui Yan,Zhenming Xu,Uday P. Pratap,Zexuan Liu,Carlos M. Roggero,Zhenqiu Tan,Susan T. Weintraub,Yan Peng,Rajeshwar R. Tekmal,Carlos L. Arteaga,Jennifer Lippincott‐Schwartz,Ratna K. Vadlamudi,Jung‐Mo Ahn,Ganesh V. Raj
摘要
In the version of this article initially published, in the legend to Extended Data Fig. 2a, the dose of ERX-41 was reported as 10 mg/kg/day for both BALB/c and nude mice, but the BALB/c mice were in fact administered 20 mg/kg/day.The correct figure legend for Extended Data Fig. 2a is "Nude mice with MDA-MB-231 xenograft tumors were treated with either a vehicle or ERX-41 (10 mg/ kg/day) for a duration of 52 days.Similarly, BALB/c mice with D2A1 xenograft tumors received a treatment of 20 mg/kg/day for 23 days.Following these treatments, histologic architecture in various organs of both the nude mice and BALB/c mice was assessed using H&E staining (a).